The experimental focus will use a combination of nanomaterials synthesis and molecular biology assays to investigate biologic regulators of nanoparticle delivery. Will join a group of multidisciplinary researchers performing cutting-edge research focused on cancer nanomedicine within the larger community of KI drug delivery researchers; and provide experimental and logistical support for multiple projects related to cancer nanotechnology using techniques ranging from nanomaterials synthesis and characterization to in vivo studies.